Ticker >

Shree Ganesh Remed. share price

Shree Ganesh Remedies Ltd.

BSE: 540737 SECTOR: Pharmaceuticals & Drugs  22k   154   9

624.95
-4.85 (-0.77%)
BSE: 25 Apr 04:01 PM

Price Summary

Today's High

₹ 637.9

Today's Low

₹ 615.2

52 Week High

₹ 736

52 Week Low

₹ 282.2

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

802.89 Cr.

Enterprise Value

825.24 Cr.

No. of Shares

1.28 Cr.

P/E

36.54

P/B

7.66

Face Value

₹ 10

Div. Yield

0.08 %

Book Value (TTM)

₹  81.58

CASH

11.15 Cr.

DEBT

33.51 Cr.

Promoter Holding

69.33 %

EPS (TTM)

₹  17.1

Sales Growth

26.56%

ROE

22.62 %

ROCE

24.67%

Profit Growth

27.03 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year26.56%
3 Year15.58%
5 Year27.04%

Profit Growth

1 Year27.03%
3 Year20.93%
5 Year29.42%

ROE%

1 Year22.62%
3 Year22.61%
5 Year22.62%

ROCE %

1 Year24.67%
3 Year28.22%
5 Year28.87%

Debt/Equity

0.3768

Price to Cash Flow

47.2

Interest Cover Ratio

196.028497409326

CFO/PAT (5 Yr. Avg.)

0.578270811463235

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 69.33 0
Dec 2023 69.33 0
Sep 2023 69.33 0
Jun 2023 69.33 0
Mar 2023 69.33 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 20.9284169984607% for the Past 3 years.
  • The company has shown a good revenue growth of 15.5842496013541% for the Past 3 years.
  • Company has been maintaining healthy ROE of 22.6051240842823% over the past 3 years.
  • Company has been maintaining healthy ROCE of 28.2192367960602% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 196.028497409326.
  • The Company has been maintaining an effective average operating margins of 24.4444174266239% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 65.0780818255384 days.
  • Company has a healthy liquidity position with current ratio of 2.70815080033698.
  • The company has a high promoter holding of 69.33%.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 21.99 29.33 26.72 33.42 27.97
Total Expenditure 16.6 21.06 19.95 24.19 19.77
Operating Profit 5.4 8.26 6.77 9.23 8.21
Other Income 1.39 0.44 0.73 0.81 1.11
Interest 0.03 0.04 0.01 0.01 0.02
Depreciation 0.99 1.03 1.02 1.41 1.88
Exceptional Items 0 0 0 0 0
Profit Before Tax 5.77 7.63 6.47 8.61 7.42
Tax 1.42 1.77 1.72 2.06 2.62
Profit After Tax 4.35 5.87 4.75 6.55 4.8
Adjusted EPS (Rs) 3.6 4.69 3.86 5.32 3.84

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 35.31 58.43 49.08 71.29 90.22
Total Expenditure 26.57 47.48 35.43 53.37 66.96
Operating Profit 8.74 10.95 13.65 17.92 23.26
Other Income 1.17 4.18 2.09 3.57 3.16
Interest 0.2 0.14 0.07 0.15 0.12
Depreciation 1.04 2.24 2.73 3.34 3.72
Exceptional Items 0 0 0 0 0
Profit Before Tax 8.67 12.74 12.95 18.01 22.58
Tax 2.43 3.12 3.2 4.61 5.56
Net Profit 6.24 9.62 9.75 13.4 17.02
Adjusted EPS (Rs.) 5.16 7.96 8.07 11.08 13.6

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 8.97 8.97 10.01 12.01 12.51
Total Reserves 24.85 33.12 40 49.57 76.43
Borrowings 0.24 0.04 0 0 30.93
Other N/C liabilities 0.49 0.45 0.41 0.4 0.14
Current liabilities 6.79 9.67 10.19 15.04 23.74
Total Liabilities 41.34 52.26 60.6 77.02 143.75
Assets
Net Block 14.5 16.27 18.85 27.19 36.25
Capital WIP 0 0 2.05 3.09 41.77
Intangible WIP 0 0 0 0 0
Investments 0.05 0.05 0.07 0.08 0.08
Loans & Advances 0.72 0.93 0.6 0.61 0.96
Other N/C Assets 0.27 0.2 1.03 1.13 0.4
Current Assets 25.81 34.82 37.99 44.91 64.29
Total Assets 41.34 52.26 60.6 77.02 143.75
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 8.67 12.74 12.95 18.01 22.58
Adjustment -0.35 -5.56 -7.84 -2.49 4.02
Changes in Assets & Liabilities -13.53 -3.31 -1.8 1.91 -3.69
Tax Paid 0 0 0 -4.01 -5.9
Operating Cash Flow -5.22 3.88 3.31 13.42 17.01
Investing Cash Flow -0.08 -2.91 -0.94 -11.91 -53.57
Financing Cash Flow -0.18 -0.21 -0.66 -1.09 41.33
Net Cash Flow -5.47 0.76 1.71 0.42 4.77

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 69.33 69.33 69.33 69.33 69.33
chandulal manubhai kothia... 41.05 41.05 48.72 48.72 48.72
gunjan chandulal kothia 3.20 3.20 3.20 3.20 3.20
hanshaben chandubhai koth... 11.42 11.42 11.42 11.42 11.42
kothia ashokkumar manubha... 0.08 0.08 0.08 0.08 0.08
manubhai jivabhai kothiya... 0.68 0.68 0.68 0.68 0.68
parth chandulal kothia 0.44 0.44 0.44 0.44 0.44
pooja gunjan kothia 4.79 4.79 4.79 4.79 4.79
ashokkumar manubhai kothi... 3.13 3.13 - - -
vilasben ashokkumar kothi... 4.55 4.55 - - -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 30.67 30.67 30.67 30.67 30.67
babubhai k kotadiya 1.66 1.66 1.66 1.66 1.66
gunjan jayantibhai dhoraj... 1.71 1.71 1.71 1.71 1.71
hansaben arvindbhai vasoy... 1.88 1.88 1.88 1.88 1.88
v naga raja naidu - - - - 1.04

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Shree Ganesh Remed. - Quaterly Results12 Feb 2024, 10:48PM Shree Ganesh Remed. - Quaterly Results12 Feb 2024, 10:48PM Shree Ganesh Remedies informs about newspaper publication13 Nov 2023, 1:02PM Shree Ganesh Remedies incorporates wholly owned subsidiary in United States25 Aug 2023, 9:59AM Shree Ganesh Remed. - Quaterly Results31 Jul 2023, 6:20PM Shree Ganesh Remed. - Quaterly Results31 Jul 2023, 6:20PM Shree Ganesh Remed. - Quaterly Results31 Jul 2023, 6:20PM Shree Ganesh Remedies gets FDA license to manufacture products at Ankleshwar facility13 Jul 2023, 1:03PM Shree Ganesh Remedies informs about analyst meet 20 Jun 2023, 5:06PM Shree Ganesh Remed. - Quaterly Results30 May 2023, 10:45PM Shree Ganesh Remed. - Quaterly Results30 May 2023, 10:45PM Shree Ganesh Remedies informs about update 27 Jan 2023, 4:52PM Shree Ganesh Remed. - Quaterly Results16 Jan 2023, 5:05PM Shree Ganesh Remed. - Quaterly Results16 Jan 2023, 5:05PM Shree Ganesh Remed. - Quaterly Results16 Jan 2023, 5:05PM Shree Ganesh Remedies informs about clarification with regards to financial results25 Oct 2022, 12:54PM Shree Ganesh Remedies informs about newspaper advertisement25 Oct 2022, 12:47PM Shree Ganesh Remedies informs about outcome of board meeting 25 Oct 2022, 10:56AM Shree Ganesh Remed. - Quaterly Results23 Oct 2022, 11:32AM Shree Ganesh Remed. - Quaterly Results12 Jul 2022, 3:39PM Shree Ganesh Remed. - Quaterly Results12 Jul 2022, 3:39PM Shree Ganesh Remed. - Quaterly Results12 Jul 2022, 3:39PM Shree Ganesh Remed. - Quaterly Results6 May 2022, 4:13PM Shree Ganesh Remed. - Quaterly Results6 May 2022, 4:13PM Shree Ganesh Remed. - Quaterly Results6 May 2022, 4:13PM Shree Ganesh Remedies informs about certificate19 Apr 2022, 1:09PM Shree Ganesh Remedies informs about postal ballot12 Mar 2022, 10:25AM Shree Ganesh Remedies informs about press release20 Jan 2022, 10:31AM Shree Ganesh Remed. - Quaterly Results18 Jan 2022, 12:36PM Shree Ganesh Remed. - Quaterly Results18 Jan 2022, 12:36PM Shree Ganesh Remed. - Quaterly Results18 Jan 2022, 12:36PM Shree Ganesh Remedies informs about allotment of bonus equity shares3 Nov 2021, 2:14PM Shree Ganesh Remedies informs about outcome of board meeting27 Oct 2021, 12:53PM Shree Ganesh Remedies informs about voting results23 Oct 2021, 12:32PM Shree Ganesh Remedies fixes record date for issue of bonus equity shares16 Oct 2021, 3:12PM Shree Ganesh Remedies acquires entire stake in Akshar Jyot8 Sep 2021, 4:56PM Shree Ganesh Remedies to acquire 74% stake in Dhari Chemicals8 Sep 2021, 9:52AM Shree Ganesh Remedies informs about investor presentation13 Jul 2021, 3:00PM Shree Ganesh Remedies informs about announcement27 May 2021, 11:47AM Shree Ganesh Remedies board recommends final dividend3 May 2021, 2:04PM Shree Ganesh Remedies informs about outcome of board meeting3 May 2021, 1:57PM Shree Ganesh Remedies gets nod for migrating Shares from SME platform to BSE24 Nov 2020, 4:16PM Shree Ganesh Remedies informs about outcome of board meeting22 Aug 2020, 9:57AM

Shree Ganesh Remed. Stock Price Analysis and Quick Research Report. Is Shree Ganesh Remed. an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Shree Ganesh Remed. and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Shree Ganesh Remed. cash from the operating activity was Rs 17.0114 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Shree Ganesh Remed. has a Debt to Equity ratio of 0.3768 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Shree Ganesh Remed. , the EPS growth was 22.779372213498 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Shree Ganesh Remed. has OPM of 25.7815374929616 % which is a good sign for profitability.
     
  • ROE: Shree Ganesh Remed. have a healthy ROE of 22.6165529429743 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Shree Ganesh Remed. is Rs 624.95. One can use valuation calculators of ticker to know if Shree Ganesh Remed. share price is undervalued or overvalued.
Last Updated on:
Brief about Shree Ganesh Remed.
X